KKSHL.BO down 11.88% pre-market 21 Mar 2026: watch INR 24.56 yearly forecast

KKSHL.BO stock opened the pre-market session on 21 Mar 2026 at INR 33.00, down -11.88% from the previous close of INR 37.45. The slide follows light trading with 6,000 shares changing hands and no scheduled earnings announcement. KK Shah Hospitals Limited (KKSHL.BO) trades on the BSE in India, carries a negative EPS of -1.51, and sits near its year low of INR 29.00. This pre-market weakness increases near-term downside risk and pressures valuation metrics ahead of any fresh operational updates.

KKSHL.BO stock: Price action, volume and immediate levels

The stock priced at INR 33.00 after opening at INR 33.50, with a day high of INR 33.50 and day low of INR 33.00. Volume is 6,000 versus an average volume of 6,600, giving a relative volume of 0.91. One clear short-term support is the year low INR 29.00, while the immediate resistance sits near the Bollinger mid band at INR 36.88 and the prior close at INR 37.45.

KKSHL.BO stock: Financials and valuation snapshot

KK Shah Hospitals Limited reports EPS -1.51 and a negative P/E of -21.85, reflecting trailing losses. Key valuation ratios include Price/Book 1.72, Price/Sales 2.50, and EV/Sales 2.41. The company shows a healthy current ratio 2.66 and cash per share INR 1.15, but free cash flow per share is negative at -6.84. These figures point to adequate liquidity but constrained cash generation.

KKSHL.BO stock: Technical setup and momentum

Momentum readings are weak. RSI is 37.27, CCI shows -121.82 (oversold), and MACD sits at -1.31 with a signal of -1.28. ATR is 3.81, so intraday swings of about INR 3.81 are typical. On the multi-day view, 50-day average is INR 40.23 and 200-day average is INR 40.90, both above the current price, which signals a medium-term downtrend.

KKSHL.BO stock: Sector context and peer comparison

KK Shah Hospitals operates in Healthcare, Medical – Care Facilities. The sector average P/E is 37.30, far above KKSHL.BO’s negative P/E. Healthcare peers trade at higher multiples and stronger profitability metrics. Sector performance year-to-date is roughly -7.60%, while KKSHL.BO is down -12.12% YTD, underperforming its sector and showing higher volatility relative to larger listed care facilities.

KKSHL.BO stock: Meyka grade and analyst-style forecast

Meyka AI rates KKSHL.BO with a score of 63.83 out of 100 (Grade: B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of INR 31.96, a quarterly price of INR 34.72, and a yearly price of INR 24.56. Versus the current price INR 33.00, the yearly forecast implies -25.57% downside. Forecasts are model-based projections and not guarantees.

KKSHL.BO stock: Risks, catalysts and trading considerations

Primary risks include continued negative net income, weak free cash flow per share -6.84, and low liquidity with average volume 6,600. Catalysts that could stabilise the stock are clear quarterly revenue growth, margin improvement, or a planned expansion that boosts utilization. Traders should watch for a volume pickup above 10,000 shares as confirmation of directional intent. Position sizing is important given the stock’s volatility and small market cap INR 224.68M.

Final Thoughts

KKSHL.BO stock is a top pre-market loser on 21 Mar 2026, trading at INR 33.00 after an -11.88% drop. Fundamentals show a negative EPS (-1.51) and strained free cash flow (-6.84 per share), which explain the weak valuation and the negative P/E. Meyka AI’s forecast model projects a yearly target of INR 24.56, implying -25.57% downside from the current price, while the quarterly model shows INR 34.72, a modest +5.21% upside. Our technicals suggest near-term support at INR 29.00 and resistance near INR 36.88. Given limited liquidity and sector peers’ stronger multiples, the stock fits a risk-tolerant watchlist rather than a core buy. Investors should use confirmation from volume and operational updates before adding exposure. These views are data-driven market analysis by Meyka AI, an AI-powered market analysis platform. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.